Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
about
Recombinant TSH-stimulated, radioguided differentiated thyroid carcinoma surgery.Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperAge modifies the response to recombinant human thyrotropin.Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastases.The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.Using recombinant human thyroid-stimulating hormone for the diagnosis of recurrent thyroid cancer.Management of thyroid cancers.Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin.Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence.High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.
P2860
Q33723307-56202B64-BFC2-4657-961F-39346C4422B2Q33825202-7C5E3972-DBB0-423E-9618-F4AD4259F332Q34342816-780D186B-F872-4AE3-94A0-D21B17E58226Q35029676-686C72D1-2205-4538-B7BC-0DAD8E179404Q35730333-E2C7A2BB-6477-41B6-A0FF-0C1EDF7E346FQ35845042-9993C5BE-3510-4F13-8B2F-6EEAB2EC8450Q36058984-1369720A-DF7C-444F-B5F0-7A583BBF8302Q36170027-4D41E3D5-E43E-4D8F-8463-474FCCC4A2E3Q36515458-D7E153FB-94C7-4E33-A593-730D19F7CE38Q37091804-71717B6F-E7B6-4AC1-AE3A-0CB5CF3C7112Q37573792-BB90AEFB-1B5C-4C8F-994D-783E81F056E8Q37733496-C98FC589-1CAE-4616-90FF-1137B9FA3403Q44060939-C3E836AE-B089-4F88-843E-5F7063FD4BF9Q44948377-C274DBA8-C961-4C72-8F5F-9321F35BA749Q46313986-17FB298C-07D1-43DE-BD9E-1F0E3B2C5C0AQ54939965-33C7258B-44E7-45AE-9860-E52D12AF1FCD
P2860
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@en
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@nl
type
label
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@en
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@nl
prefLabel
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@en
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@nl
P2093
P356
P1476
Prediction of disease status b ...... ferentiated thyroid carcinoma.
@en
P2093
Capezzone M
Castagna MG
Ceccarelli C
Molinaro E
Pinchera A
P304
P356
10.1210/JC.86.12.5686
P407
P577
2001-12-01T00:00:00Z